Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
VYNE Therapeutics (VYNE) Q3 2023 Earnings
VYNE
13
Nov
Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-3.24
-2.65
-2.07
-1.48
Details
Expected EPS
-1.97
Actual EPS
-1.75
Surprise EPS
0.22
Surprise Percent
+11.17%
Description
VYNE Therapeutics (VYNE) has reported earnings of -1.75 per share for Q3 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login